Abbott: US baby formula plant linked to national shortage resumes productionon June 4, 2022 at 6:35 pm

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Abbott says it is restarting its plant in Michigan after it was closed because of contamination.

This video can not be played

To play this video you need to enable JavaScript in your browser.

US firm Abbott says it is restarting production at a baby formula plant after its shutdown contributed to a national shortage of the baby food.

The plant in Michigan – one of America’s largest – was closed in February because of contamination.

Coupled with global supply chain issues, the factory’s closure led to acute shortages.

Parents were left scrambling for supplies, seeking formula from food banks, friends and doctor’s offices.

Some turned to social media to try to track down baby milk, while others attempted to make their own substitutes (against medical advice).

The facility has met initial government sanitary requirements for reopening, the company said in a statement.

Abbott said it would initially prioritise the production of its EleCare speciality formulas for babies with severe food allergies and digestive problems.

“We’re also working hard to fulfil the steps necessary to restart production of Similac and other formulas,” Abbott said, referring to its more mainstream products. It plans to ramp up production as quickly as possible “while meeting all requirements”, it said.

The company said it would take about three weeks before new formula from the plant began reaching stores.

Last month, US President Joe Biden invoked the Defense Production Act, a war-time measure, to boost domestic production of formula, and ordered the Pentagon to fly in shipments from overseas.

A bill to alleviate the shortage was also overwhelmingly passed by the House of Representatives.

Other countries have supplied formula to boost supplies during the crisis.

The Abbott plant shut down in February after the death of two babies, and the company issued a product recall amid concerns over bacterial contamination.

Inspectors for the Food and Drug Administration (FDA) say they uncovered a number of anomalies at the plant, including bacterial contamination, leaks in the roof and a lack of basic hygiene.

The company says there is no conclusive evidence linking its products to infant illnesses or deaths.

- Advertisement -

Discover

Sponsor

Latest

Burnley 1-1 Leicester: Kelechi Iheanacho earns Foxes’ a drawon March 3, 2021 at 8:15 pm

Kelechi Iheanacho steps up superbly in the absence of a number of injured team-mates to earn Leicester a potentially important draw at Burnley.By Phil...

William Ruto: How Kenya’s new president is influenced by religionon September 12, 2022 at 11:22 pm

William Ruto is Kenya's first evangelical Christian president and is likely to put religion centre-stage.William Ruto is Kenya's first evangelical Christian president and is...

The NHS hidden waiting lists terrifying patientson February 19, 2024 at 3:02 am

Patients are facing delays for ongoing cancer care, heart check-ups and eye treatment in England.Image source, Anton PetrusBy Nick TriggleHealth correspondentPatients are facing delays...

Kenya’s election wrestling match: Dynasties v Hustlerson August 5, 2022 at 11:48 pm

As the president backs his ex-rival in elections, his deputy says he is fighting dynastic rule.As the president backs his ex-rival in elections, his...

Ireland leader Leo Varadkar has ‘regrets’ over NI protocolon January 20, 2023 at 4:57 am

The Taoiseach says the post-Brexit measure was imposed on unionists and nationalists without their consent.This video can not be playedTo play this video you...